Transmural dispersion of repolarization determines scroll wave behavior during ventricular tachyarrhythmias

Circ J. 2011;75(1):80-8. doi: 10.1253/circj.cj-10-0071. Epub 2010 Nov 16.

Abstract

Background: Ventricular tachyarrhythmia is the leading cause of sudden cardiac death, and scroll wave re-entry is known to underlie this condition. Class III antiarrhythmic drugs are commonly used worldwide to treat ventricular tachyarrhythmias; however, these drugs have a proarrhythmic adverse effect and can cause Torsade de Pointes or ventricular fibrillation. Transmural dispersion of repolarization (TDR) has been suggested to be a strong indicator of ventricular tachyarrhythmia induction. However, the role of TDR during sustained scroll wave re-entry is poorly understood. The purpose of the present study was to investigate how TDR affects scroll wave behavior and to provide a novel analysis of the mechanisms that sustain tachyarrhythmias, using computer simulations.

Methods and results: Computer simulations were carried out to quantify the TDR and QT interval under a variety of I(Ks) and I(Kr) during transmural conduction. Simulated scroll wave re-entries were done under a variety of I(Ks) and I(Kr) in a ventricular wall slab model, and the scroll wave behavior and the filament dynamics (3-dimensional organizing center) were analyzed. A slight increase in TDR, but not in the QT interval, reflected antiarrhythmic properties resulting from the restraint of scroll wave breakup, whereas a marked increase in TDR was proarrhythmic, as a result of scroll wave breakup.

Conclusions: The TDR determines the sustainment of ventricular tachyarrhythmias, through control of the scroll wave filament dynamics.

Publication types

  • Research Support, Non-U.S. Gov't
  • Video-Audio Media

MeSH terms

  • Action Potentials
  • Anti-Arrhythmia Agents / adverse effects
  • Computer Simulation*
  • Heart Conduction System / drug effects
  • Heart Conduction System / metabolism
  • Heart Conduction System / physiopathology*
  • Heart Ventricles / drug effects
  • Heart Ventricles / metabolism
  • Heart Ventricles / physiopathology*
  • Humans
  • Imaging, Three-Dimensional
  • Kinetics
  • Models, Cardiovascular*
  • Myocytes, Cardiac / metabolism
  • Potassium / metabolism
  • Potassium Channels / metabolism
  • Tachycardia, Ventricular / drug therapy
  • Tachycardia, Ventricular / etiology
  • Tachycardia, Ventricular / metabolism
  • Tachycardia, Ventricular / physiopathology*
  • Torsades de Pointes / etiology
  • Torsades de Pointes / physiopathology
  • Ventricular Fibrillation / etiology
  • Ventricular Fibrillation / metabolism
  • Ventricular Fibrillation / physiopathology*

Substances

  • Anti-Arrhythmia Agents
  • Potassium Channels
  • Potassium